Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deokhoon Kim

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 15, 2025
Clinicopathologic and genomic analyses of SMARCA4-mutated non-small cell lung carcinoma implicate the needs for tailored treatment strategiesBokyung Ahn, Deokhoon Kim, Wonjun Ji, et al.
Frontiers in Oncology|November 5, 2019
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial TumorsJoon Seon Song, Deokhoon Kim, Ji Hyun Kwon, et al.
Plos One|March 7, 2014
Comparative genomic analysis of primary and synchronous metastatic colorectal cancersSun Young Lee, Farhan Haq, Deokhoon Kim, et al.
Human Pathology|June 6, 2022
Pancreatic ductal adenocarcinoma with a predominant large duct pattern has better recurrence-free survival than conventional pancreatic ductal adenocarcinoma: a comprehensive histopathological, immunohistochemical, and mutational studySung Joo Kim, Se Jin Choi, Junmo Yang, et al.
Cancer Research and Treatment|December 26, 2023
Invasiveness of Upper Tract Urothelial Carcinoma: Clinical Significance and Integrative Diagnostic StrategyBokyung Ahn, Doeun Kim, Kye Jin Park, et al.
BMC Cancer|April 10, 2022
Predictive biomarkers for the efficacy of nivolumab as ≥ 3<sup>rd</sup>-line therapy in patients with advanced gastric cancer: a subset analysis of ATTRACTION-2 phase III trialJwa Hoon Kim, Min-Hee Ryu, Young Soo Park, et al.
Lung Cancer (Amsterdam, Netherlands)|July 12, 2022
Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinomaBokyung Ahn, Shinkyo Yoon, Deokhoon Kim, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 27, 2022
Clinicogenomic Characteristics and Treatment of Young-Onset Colorectal Cancer Patients Treated With Palliative Therapy in Real-World PracticeHyehyun Jeong, Eunjung Lee, Deokhoon Kim, et al.
Cancer Letters|August 12, 2017
The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancerKang-Seo Park, Hannah Yang, Junyoung Choi, et al.
BMB Reports|June 26, 2019
Mitochondrial genome mutations in mesenchymal stem cells derived from human dental induced pluripotent stem cellsJumi Park, Yeonmi Lee, Joosung Shin, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Lung Cancer (Amsterdam, Netherlands)|February 15, 2025
Clinicopathologic and genomic analyses of SMARCA4-mutated non-small cell lung carcinoma implicate the needs for tailored treatment strategiesBokyung Ahn, Deokhoon Kim, Wonjun Ji, et al.
Frontiers in Oncology|November 5, 2019
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial TumorsJoon Seon Song, Deokhoon Kim, Ji Hyun Kwon, et al.
Plos One|March 7, 2014
Comparative genomic analysis of primary and synchronous metastatic colorectal cancersSun Young Lee, Farhan Haq, Deokhoon Kim, et al.
Human Pathology|June 6, 2022
Pancreatic ductal adenocarcinoma with a predominant large duct pattern has better recurrence-free survival than conventional pancreatic ductal adenocarcinoma: a comprehensive histopathological, immunohistochemical, and mutational studySung Joo Kim, Se Jin Choi, Junmo Yang, et al.
Cancer Research and Treatment|December 26, 2023
Invasiveness of Upper Tract Urothelial Carcinoma: Clinical Significance and Integrative Diagnostic StrategyBokyung Ahn, Doeun Kim, Kye Jin Park, et al.
BMC Cancer|April 10, 2022
Predictive biomarkers for the efficacy of nivolumab as ≥ 3<sup>rd</sup>-line therapy in patients with advanced gastric cancer: a subset analysis of ATTRACTION-2 phase III trialJwa Hoon Kim, Min-Hee Ryu, Young Soo Park, et al.
Lung Cancer (Amsterdam, Netherlands)|July 12, 2022
Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinomaBokyung Ahn, Shinkyo Yoon, Deokhoon Kim, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 27, 2022
Clinicogenomic Characteristics and Treatment of Young-Onset Colorectal Cancer Patients Treated With Palliative Therapy in Real-World PracticeHyehyun Jeong, Eunjung Lee, Deokhoon Kim, et al.
Cancer Letters|August 12, 2017
The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancerKang-Seo Park, Hannah Yang, Junyoung Choi, et al.
BMB Reports|June 26, 2019
Mitochondrial genome mutations in mesenchymal stem cells derived from human dental induced pluripotent stem cellsJumi Park, Yeonmi Lee, Joosung Shin, et al.
Pageof 7